BMRN
#799
BioMarin Pharmaceutical Inc. - Common Stock
64.6 7 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.95%
Variación mensual
+6.72%
Variación en los últimos 6 meses
+6.52%
Cambio anual
+10.74%
Cierres anteriores
65.2 9
Open
64.6 7
Mínimo
64.6 7
Máximo
64.6 7
Volumen
131
Financials
- Market Capitalization 12.52 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
33.02
Relación precio/flujo de caja
3.64
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 710 |  BBIO BridgeBio Pharma, Inc. - Common Stock | 76.60 USD | -2.64% | -5.42% | -4.32% | +34.39% | 14.97 B USD | ||
| 761 |  EXEL Exelixis, Inc. - Common Stock | 54.45 USD | -1.47% | +1.04% | -0.82% | +39.47% | 13.49 B USD | ||
| 809 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 533.76 USD | -1.83% | +3.24% | +5.58% | +26.00% | 12.33 B USD | ||
| 810 |  CORT Corcept Therapeutics Incorporated - Common Stock | 113.88 USD | -2.61% | -5.54% | +1.68% | +55.21% | 12.31 B USD |